Suppr超能文献

纤维蛋白原和纤维蛋白I对凝血酶原内在激活的调节作用I。

Modulation of intrinsic prothrombin activation by fibrinogen and fibrin I.

作者信息

Okwusidi J I, Anvari N, Ofosu F A

机构信息

Department of Pathology, McMaster University, Hamilton, Ontario, Canada.

出版信息

J Lab Clin Med. 1993 Jan;121(1):64-70.

PMID:8426082
Abstract

Recent observations raise the possibility that by binding thrombin, fibrin(ogen) could modulate prothrombin activation, perhaps by modulating thrombin-mediated activation of factors VIII and V. Factors VIIIa and Va are the cofactors of intrinsic tenase and prothrombinase, respectively. This study compared the profile of prothrombin activation in pooled normal plasma, defibrinated pooled normal plasma, and pooled normal plasma containing fibrin I. Prothrombin activation was initiated with three stimuli, as follows: (1) addition of a suspension of thrombin, CaCl2, and coagulant phospholipids to plasma; (2) contact activation followed by recalcification of plasma; and (3) addition of a suspension of crude rabbit brain tissue factor and CaCl2 to plasma. Each plasma sample contained 2 mmol/L gly-pro-arg-pro, which prevents the polymerization of fibrin. Prothrombin activation, indexed as the concentration of prothrombin activation fragment 1 + 2 produced, was quantitated by enzyme-linked immunosorbent assay. Fibrinogen significantly delayed the onset of prothrombin activation initiated by thrombin or by contact activation but not that initiated with tissue factor. In contrast, fibrin I in solution accelerated prothrombin activation initiated with thrombin or by contact activation. Although fibrinogen had no effect on intrinsic activation of factor IX or factor IX activation initiated by adding thrombin to plasma, it inhibited factor X activation initiated with either stimuli. We therefore conclude that fibrinogen can inhibit the activation of factor X and prothrombin. Second, fibrin I accelerates prothrombin activation. Fibrinogen and fibrin, therefore, have the potential to bioregulate blood coagulation.

摘要

最近的观察结果提示,纤维蛋白(原)通过结合凝血酶,可能调节凝血酶原激活,或许是通过调节凝血酶介导的因子Ⅷ和Ⅴ的激活。因子Ⅷa和Ⅴa分别是内源性凝血酶原酶和凝血酶原酶的辅因子。本研究比较了正常混合血浆、去纤维蛋白正常混合血浆和含有纤维蛋白Ⅰ的正常混合血浆中凝血酶原激活的情况。凝血酶原激活通过三种刺激启动,如下:(1)向血浆中加入凝血酶、氯化钙和促凝磷脂悬浮液;(2)接触激活后再对血浆重新钙化;(3)向血浆中加入粗制兔脑组织因子和氯化钙悬浮液。每个血浆样本含有2 mmol/L甘-脯-精-脯,以防止纤维蛋白聚合。以产生的凝血酶原激活片段1 + 2的浓度为指标,通过酶联免疫吸附测定法定量凝血酶原激活。纤维蛋白原显著延迟了由凝血酶或接触激活启动的凝血酶原激活的起始,但未延迟由组织因子启动的凝血酶原激活的起始。相比之下,溶液中的纤维蛋白Ⅰ加速了由凝血酶或接触激活启动的凝血酶原激活。虽然纤维蛋白原对因子Ⅸ的内源性激活或向血浆中加入凝血酶引发的因子Ⅸ激活没有影响,但它抑制了由任何一种刺激引发的因子Ⅹ激活。因此,我们得出结论,纤维蛋白原可以抑制因子Ⅹ和凝血酶原的激活。其次,纤维蛋白Ⅰ加速凝血酶原激活。因此,纤维蛋白原和纤维蛋白具有对血液凝固进行生物调节的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验